We have a miraculous anti-aging vaccine. Why aren’t more people getting it?
vox.com • • health
Key Points:
- The shingles vaccine, initially developed to prevent painful shingles outbreaks, may also reduce the risk of dementia by 20% and slow biological aging, according to recent studies from Wales, Australia, Canada, and biomarker analyses in the US.
- The newer shingles vaccine, Shingrix, which is more effective than the original, has unknown anti-aging effects due to a lack of clinical trials, as researchers face difficulties securing funding for further study.
- Despite the vaccine’s potential benefits, vaccination rates remain low, with less than 30% of eligible Americans over 50 receiving the shot, partly due to healthcare access issues and rising vaccine hesitancy among seniors.
- Experts emphasize the need for increased research investment and public health efforts to boost vaccine uptake
